Compare Ascendis Pharma A/S (ASND) vs Cintas Corporation (CTAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Cintas Corporation — how do they compare? Ascendis Pharma A/S trades at $254.01 (market cap $16.67B), while Cintas Corporation trades at $205.28 (market cap $82.15B). The key difference: Cintas Corporation is far larger — about 4.9× Ascendis Pharma A/S's market cap, and Cintas Corporation pays a 1.01% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | CTAS | |
|---|---|---|
Market Cap | $16.67B | $82.15B |
Sector | Health | Industrials |
52-Week High | $277.18 | $225.10 |
52-Week Low | $189.74 | $163.55 |
Enterprise Value | $17.04B | $84.56B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →
